A study in the Journal of the American Medical Association (JAMA) Psychiatry concluded that the majority of states will likely legalize psychedelics by 2037.
The potential of psychedelics to treat mental health issues such as depression, anxiety, and PTSD is well-documented. With the legalization of psychedelics, more research can be conducted to further explore the therapeutic potential of these substances.
From the release:
After analyzing data from various sources such as BillTrack50, LexisNexis, and Ballotpedia, it was discovered that 74 bills regarding psychedelics have been considered in half of the states across America. These include 69 legislative proposals and five ballot measures. Out of these, 10 bills were enacted while 32 remain active. Furthermore, the majority of these reform measures focus on psilocybin with MDMA being the second most mentioned substance.
The researchers noted that “the results of ‘their’ study showed that, after decades of legal restriction, US states have been swiftly moving toward increased access to psychedelics.”
The findings of this study are encouraging and suggest that the US is on the path to a more progressive and open-minded approach to psychedelics. It is likely that more states will follow suit and legalize psychedelics in the coming years.